We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$70.4B
AUM Growth
+$4.22B
Cap. Flow
+$691M
Cap. Flow %
0.98%
Top 10 Hldgs %
28.49%
Holding
1,436
New
73
Increased
766
Reduced
481
Closed
68

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$479M
2
INTC icon
Intel
INTC
+$427M
3
WDAY icon
Workday
WDAY
+$223M
4
KVUE icon
Kenvue
KVUE
+$209M
5
ADBE icon
Adobe
ADBE
+$207M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$760M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$245M
3
TER icon
Teradyne
TER
+$243M
4
WFC icon
Wells Fargo
WFC
+$228M
5
ECL icon
Ecolab
ECL
+$223M

Sector Composition

Rank Sector Weight
1 Technology 42.18%
2 Materials 24.65%
3 Healthcare 6.97%
4 Industrials 5.85%
5 Financials 4.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXG icon
1301
10x Genomics
TXG
$5.88B
$41K ﹤0.01%
2,122
-111
-5% -$2.91K
EVH icon
1302
Evolent Health
EVH
$371M
$39K ﹤0.01%
2,033
-345
-15% -$8.81K
RDY icon
1303
Dr. Reddy's Laboratories
RDY
$9.8B
$38K ﹤0.01%
2,505
TDOC icon
1304
Teladoc Health
TDOC
$1.66B
$37K ﹤0.01%
3,817
NEO icon
1305
NeoGenomics
NEO
$1.96B
$35K ﹤0.01%
2,506
SENEA icon
1306
Seneca Foods Class A
SENEA
$1.15B
$34K ﹤0.01%
595
+46
+8% +$2.68K
DGRW icon
1307
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.5B
$33K ﹤0.01%
426
TWST icon
1308
Twist Bioscience
TWST
$5.32B
$33K ﹤0.01%
660
+46
+7% +$1.88K
XOP icon
1309
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.54B
$33K ﹤0.01%
219
-28,435
-99% -$4.3M
IHDG icon
1310
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.2B
$32K ﹤0.01%
706
SDVY icon
1311
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.5B
$32K ﹤0.01%
963
HYD icon
1312
VanEck High Yield Muni ETF
HYD
$4.44B
$31K ﹤0.01%
595
+8
+1% +$413
LKFT
1313
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$30K ﹤0.01%
1,209
ITM icon
1314
VanEck Intermediate Muni ETF
ITM
$2.14B
$30K ﹤0.01%
656
+4
+0.6% +$184
OMCL icon
1315
Omnicell
OMCL
$1.88B
$28K ﹤0.01%
1,049
FHI icon
1316
Federated Hermes
FHI
$4.56B
$27K ﹤0.01%
816
-81
-9% -$2.72K
FLTR icon
1317
VanEck IG Floating Rate ETF
FLTR
$2.94B
$27K ﹤0.01%
1,042
+778
+295% +$19.8K
PHR icon
1318
Phreesia
PHR
$689M
$25K ﹤0.01%
1,164
XIFR
1319
XPLR Infrastructure LP
XIFR
$1.04B
$25K ﹤0.01%
905
-648
-42% -$19.7K
BEAM icon
1320
Beam Therapeutics
BEAM
$2.68B
$24K ﹤0.01%
1,040
-105
-9% -$2.58K
CLOI icon
1321
VanEck CLO ETF
CLOI
$1.49B
$24K ﹤0.01%
+453
New +$23.9K
ZTO icon
1322
ZTO Express
ZTO
$18.2B
$24K ﹤0.01%
1,135
LAUR icon
1323
Laureate Education
LAUR
$5.38B
$22K ﹤0.01%
1,496
-22
-1% -$329
ITUB icon
1324
Itaú Unibanco
ITUB
$89.8B
$21K ﹤0.01%
4,081
MLN icon
1325
VanEck Long Muni ETF
MLN
$679M
$21K ﹤0.01%
1,153
+12
+1% +$214

Similar funds

VanEck Associates's Q2 2024 Portfolio in Review

As of Q2 2024, VanEck Associates held 1,436 positions worth $70.4B, up 6.4% from $66.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

VanEck Associates's Q2 2024 filing shows 73 new, 766 increased, 481 reduced and 68 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 659,222 shares worth $180M. The largest sale was NVIDIA, an estimated $760M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 37% a quarter earlier, followed by Materials and Healthcare.

  • VanEck Associates's largest Q2 2024 buy was Bio-Rad Laboratories Class A: 659,222 shares worth $180M.
  • VanEck Associates added most to Advanced Micro Devices in Q2 2024, an estimated $479M increase.
  • VanEck Associates's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $760M.
  • VanEck Associates fully exited Wells Fargo in Q2 2024, selling an estimated $228M.
  • VanEck Associates's ten largest holdings make up 28% of its $70.4B portfolio in Q2 2024.
  • VanEck Associates opened 73 new positions and closed 68 in Q2 2024.
  • VanEck Associates's portfolio value rose 6.4% quarter-over-quarter to $70.4B.

Based on VanEck Associates's 13F filing for Q2 2024, filed 31 Jul 2024.